Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Consolidated Net Income (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Consolidated Net Income data on record, last reported at $2.6 million in Q3 2025.

  • For Q3 2025, Consolidated Net Income fell 26.16% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $24.8 million, up 615.81%, while the annual FY2024 figure was $13.9 million, 13.36% down from the prior year.
  • Consolidated Net Income reached $2.6 million in Q3 2025 per UTMD's latest filing, down from $3.0 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $16.1 million in Q4 2024 and bottomed at -$7.9 million in Q4 2022.
  • Average Consolidated Net Income over 5 years is $3.1 million, with a median of $3.6 million recorded in 2024.
  • Peak YoY movement for Consolidated Net Income: plummeted 291.67% in 2022, then soared 314.39% in 2024.
  • A 5-year view of Consolidated Net Income shows it stood at $4.1 million in 2021, then tumbled by 291.67% to -$7.9 million in 2022, then rose by 5.24% to -$7.5 million in 2023, then skyrocketed by 314.39% to $16.1 million in 2024, then tumbled by 83.65% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Consolidated Net Income were $2.6 million in Q3 2025, $3.0 million in Q2 2025, and $3.0 million in Q1 2025.